作者：
Timothy A.,Yap [1]
;
Elisa,Fontana [2]
;
Elizabeth K.,Lee [3]
;
David R.,Spigel [4]
;
Martin,H?jgaard [5]
;
Stephanie,Lheureux [6]
;
Niharika B.,Mettu [7]
;
Benedito A.,Carneiro [8]
;
Louise,Carter [9]
;
Ruth,Plummer [10]
;
Gregory M.,Cote [11]
;
Funda,Meric-Bernstam [12]
;
Joseph,O’Connell [13]
;
Joseph D.,Schonhoft [14]
;
Marisa,Wainszelbaum ;
Adrian J.,Fretland ;
Peter,Manley ;
Yi,Xu ;
Danielle,Ulanet ;
Victoria,Rimkunas ;
Mike,Zinda ;
Maria,Koehler ;
Ian M.,Silverman ;
Jorge S.,Reis-Filho ;
Ezra,Rosen
作者单位：
Department of Investigational Cancer Therapeutics,The University of Texas MD Anderson Cancer Center
[1]
Sarah Cannon Research Institute UK
[2]
Department of Medical Oncology,Dana-Farber Cancer Institute
[3]
Sarah Cannon Research Institute/Tennessee Oncology
[4]
Department of Oncology,Rigshospitalet
[5]
Princess Margaret Cancer Centre
[6]
Department of Medical Oncology,Duke University
[7]
Legorreta Cancer Center at Brown University and Lifespan Cancer Institute, Division of Hematology
[8]
Division of Cancer Sciences,University of Manchester and the Christie NHS Foundation Trust
[9]
Newcastle University and Newcastle Hospitals NHS Foundation Trust, Northern Centre for Cancer Care
[10]
Repare Therapeutics
[11]
Department of Pathology,Memorial Sloan Kettering Cancer Center
[12]
Department of Medical Oncology,Memorial Sloan Kettering Cancer Center
[13]
Massachusetts General Hospital Cancer Center
[14]
发布时间
2023-10-24
换一批
